ARTG Entry

TABRECTA

ARTG entry for TABRECTA (capmatinib), ARTG 489646 — Product Information, dosage form, registration history. Compiled by arcimedes.

• Sponsor: Novartis Pharmaceuticals
• Active ingredient: capmatinib
• Therapeutic area: Oncology

TGA Public Summary — ARTG 489646